Latest News & Updates on Raydiant Oximetry Technology
Stay up-to-date with the latest press releases and company news. Explore insights, announcements, and milestones as we share our journey and keep you connected to what’s happening at Raydiant Oximetry.
Raydiant Oximetry Names Michael Nagel to Lead the Company into its Device Commercialization Stage as CEO
SAN RAMON, CA, UNITED STATES, September 16, 2025 — Raydiant Oximetry, Inc. a clinical-stage medical device company developing fetal monitoring innovations using advanced biophotonics and machine learning to improve outcomes during childbirth, today announced the appointment of Michael Nagel as Chief Executive Officer.
GE HealthCare and Raydiant Oximetry accelerate innovation in fetal oxygen saturation technology
GE HealthCare and Raydiant Oximetry, Inc. today announced a joint development initiative to enhance fetal monitoring capabilities that could strengthen the support of clinical decision-making during labor. This effort leverages the combined expertise and technology of the two companies to advance fetal oxygen saturation monitoring technology with the goal of
Raydiant Oximetry Wins First Place in NIH RADx® Tech Fetal Monitoring Challenge Securing $750,000 in Prize Money
This challenge, co-sponsored by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and the Bill & Melinda Gates Foundation, aims to accelerate the development of advanced fetal monitoring technologies to improve fetal and neonatal outcomes.
Raydiant Oximetry Secures $1 Million Grant to Advance Fetal Monitoring Technology
Raydiant Oximetry, Inc., a clinical-stage medical device company developing innovations to keep mothers and babies safe during childbirth, has announced the receipt of a $1 million grant from the Bill & Melinda Gates Foundation.
Raydiant Oximetry Kicks Off Series B Financing Round with an Investment from March of Dimes
Raydiant Oximetry, Inc., announced that it has received an investment from the March of Dimes Innovation Fund to kick off its Series B financing round.
AngelMD Portfolio Company Raydiant Oximetry Awarded FDA Breakthrough Device Status
The accelerated path to approval through the breakthrough device program will enable better care to millions of mothers and babies during childbirth.
Raydiant Oximetry Names Michael Nagel to Lead the Company into its Device Commercialization Stage as CEO
SAN RAMON, CA, UNITED STATES, September 16, 2025 — Raydiant Oximetry, Inc. a clinical-stage medical device company developing fetal monitoring innovations using advanced biophotonics and machine learning to improve outcomes during childbirth, today announced the appointment of Michael Nagel as Chief Executive Officer.
GE HealthCare and Raydiant Oximetry accelerate innovation in fetal oxygen saturation technology
GE HealthCare and Raydiant Oximetry, Inc. today announced a joint development initiative to enhance fetal monitoring capabilities that could strengthen the support of clinical decision-making during labor. This effort leverages the combined expertise and technology of the two companies to advance fetal oxygen saturation monitoring technology with the goal of
Raydiant Oximetry Wins First Place in NIH RADx® Tech Fetal Monitoring Challenge Securing $750,000 in Prize Money
This challenge, co-sponsored by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and the Bill & Melinda Gates Foundation, aims to accelerate the development of advanced fetal monitoring technologies to improve fetal and neonatal outcomes.
Raydiant Oximetry Secures $1 Million Grant to Advance Fetal Monitoring Technology
Raydiant Oximetry, Inc., a clinical-stage medical device company developing innovations to keep mothers and babies safe during childbirth, has announced the receipt of a $1 million grant from the Bill & Melinda Gates Foundation.
Raydiant Oximetry Kicks Off Series B Financing Round with an Investment from March of Dimes
Raydiant Oximetry, Inc., announced that it has received an investment from the March of Dimes Innovation Fund to kick off its Series B financing round.
AngelMD Portfolio Company Raydiant Oximetry Awarded FDA Breakthrough Device Status
The accelerated path to approval through the breakthrough device program will enable better care to millions of mothers and babies during childbirth.